| NCT02376816 |
Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02376816 |
Completed |
Nationwide Children’s Hospital |
2017-09-30 |
| NCT03406780 |
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03406780 |
Completed |
Capricor Inc. |
2020-03-10 |
| NCT03375255 |
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 in Patients With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT03375255 |
Completed |
Sarepta Therapeutics, Inc. |
2019-08-19 |
| NCT03375164 |
Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03375164 |
Active, not recruiting |
Sarepta Therapeutics, Inc. |
2021-04-30 |
| NCT03373968 |
Givinostat in Duchenne’s Muscular Dystrophy Long-term Safety and Tolerability Study |
https://ClinicalTrials.gov/show/NCT03373968 |
Recruiting |
Italfarmaco |
2023-12-31 |
| NCT03362502 |
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03362502 |
Recruiting |
Pfizer |
2021-08-26 |
| NCT03340675 |
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03340675 |
Recruiting |
Cumberland Pharmaceuticals |
2023-07-31 |
| NCT03333590 |
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03333590 |
Active, not recruiting |
Nationwide Children’s Hospital |
2020-11-30 |
| NCT03317171 |
Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies |
https://ClinicalTrials.gov/show/NCT03317171 |
Completed |
Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico |
2016-12-31 |
| NCT03238235 |
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03238235 |
Recruiting |
Italfarmaco |
2020-05-31 |
| NCT03236662 |
(-)- Epicatechin Becker Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03236662 |
Completed |
University of California, Davis |
2017-11-30 |
| NCT03218995 |
Study of Eteplirsen in Young Patients With DMD Amenable to Exon 51 Skipping |
https://ClinicalTrials.gov/show/NCT03218995 |
Active, not recruiting |
Sarepta Therapeutics, Inc. |
2021-03-15 |
| NCT03179631 |
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03179631 |
Recruiting |
PTC Therapeutics |
2023-09-05 |
| NCT03167255 |
Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT03167255 |
Active, not recruiting |
NS Pharma, Inc. |
2021-05-31 |
| NCT03127241 |
User-centred Assistive System for Arm Functions in Neuromuscular Subjects |
https://ClinicalTrials.gov/show/NCT03127241 |
Completed |
Politecnico di Milano |
2019-11-30 |
| NCT03123913 |
Study of Testosterone and rHGH in FSHD |
https://ClinicalTrials.gov/show/NCT03123913 |
Recruiting |
University of Rochester |
2021-04-30 |
| NCT03067831 |
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03067831 |
Recruiting |
Stem Cells Arabia |
2021-11-30 |
| NCT03038399 |
Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT03038399 |
Active, not recruiting |
ReveraGen BioPharma, Inc. |
2020-04-30 |
| NCT03002298 |
Virtual Reality in Individuals With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03002298 |
Completed |
University of Sao Paulo |
2016-08-31 |
| NCT02964377 |
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents |
https://ClinicalTrials.gov/show/NCT02964377 |
Completed |
University of California, Davis |
2018-07-31 |
| NCT02891434 |
Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02891434 |
Completed |
University of Sao Paulo |
2016-10-31 |
| NCT02851797 |
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02851797 |
Recruiting |
Italfarmaco |
2022-03-31 |
| NCT02847975 |
Sodium Nitrate to Improve Blood Flow |
https://ClinicalTrials.gov/show/NCT02847975 |
Completed |
Cedars-Sinai Medical Center |
2014-12-31 |
| NCT02836418 |
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02836418 |
Completed |
aTyr Pharma, Inc. |
2017-04-18 |
| NCT02835079 |
Treatment Effect of Tamoxifen on Patients With DMD |
https://ClinicalTrials.gov/show/NCT02835079 |
Active, not recruiting |
Hadassah Medical Organization |
2020-11-30 |
| NCT02834650 |
Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD |
https://ClinicalTrials.gov/show/NCT02834650 |
Recruiting |
University of California, Los Angeles |
2021-01-31 |
| NCT02819557 |
Study of Ataluren in ≥2 to <5 Year-Old Males With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02819557 |
Completed |
PTC Therapeutics |
2018-02-09 |
| NCT02814110 |
Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02814110 |
Recruiting |
Medical University of Bialystok |
2020-12-31 |
| NCT02760277 |
An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02760277 |
Completed |
ReveraGen BioPharma, Inc. |
2018-04-26 |
| NCT02760264 |
A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02760264 |
Completed |
ReveraGen BioPharma, Inc. |
2018-05-01 |
| NCT02752048 |
A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02752048 |
Completed |
Taiho Pharmaceutical Co., Ltd. |
2017-05-15 |
| NCT02740972 |
Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02740972 |
Completed |
NS Pharma, Inc. |
2018-03-31 |
| NCT02710591 |
Rimeporide in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02710591 |
Completed |
EspeRare Foundation |
2017-12-31 |
| NCT02667483 |
Study of DS-5141b in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02667483 |
Active, not recruiting |
Daiichi Sankyo, Inc. |
2020-12-31 |
| NCT02606136 |
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02606136 |
Active, not recruiting |
FibroGen |
2020-04-30 |
| NCT02603562 |
Evaluate Safety and Biological Activity of ATYR1940 in Patients With Early Onset Facioscapulohumeral Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02603562 |
Completed |
aTyr Pharma, Inc. |
2016-12-13 |
| NCT02500381 |
Study of SRP-4045 and SRP-4053 in DMD Patients |
https://ClinicalTrials.gov/show/NCT02500381 |
Recruiting |
Sarepta Therapeutics, Inc. |
2022-05-31 |
| NCT01961557 |
Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders |
https://ClinicalTrials.gov/show/NCT01961557 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-05-22 |
| NCT02531217 |
Safety, Tolerability, PK, and Activity of ATYR1940 in Patients With Muscular Dystrophy - Study Extension |
https://ClinicalTrials.gov/show/NCT02531217 |
Completed |
aTyr Pharma, Inc. |
2017-03-14 |
| NCT02530905 |
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients |
https://ClinicalTrials.gov/show/NCT02530905 |
Completed |
Sarepta Therapeutics, Inc. |
2018-10-03 |
| NCT02522507 |
A Peer E-mentoring Intervention to Improve Employment |
https://ClinicalTrials.gov/show/NCT02522507 |
Recruiting |
Holland Bloorview Kids Rehabilitation Hospital |
2019-04-30 |
| NCT02516085 |
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin |
https://ClinicalTrials.gov/show/NCT02516085 |
Completed |
University Hospital, Basel, Switzerland |
2012-10-31 |
| NCT02485938 |
HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) |
https://ClinicalTrials.gov/show/NCT02485938 |
Completed |
Capricor Inc. |
2017-09-30 |
| NCT02439216 |
Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02439216 |
Completed |
Catabasis Pharmaceuticals |
2017-01-12 |
| NCT02434627 |
Sodium Nitrate for Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02434627 |
Completed |
Cedars-Sinai Medical Center |
2018-04-30 |
| NCT02432885 |
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial |
https://ClinicalTrials.gov/show/NCT02432885 |
Completed |
InCor Heart Institute |
2012-06-30 |
| NCT02428673 |
Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions |
https://ClinicalTrials.gov/show/NCT02428673 |
Active, not recruiting |
Gillette Children’s Specialty Healthcare |
2019-03-31 |
| NCT02421523 |
Strength Training in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02421523 |
Completed |
University of Florida |
2018-02-15 |
| NCT02420379 |
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02420379 |
Completed |
Sarepta Therapeutics, Inc. |
2018-12-17 |
| NCT02418338 |
2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children |
https://ClinicalTrials.gov/show/NCT02418338 |
Completed |
University Hospital, Montpellier |
2017-06-30 |
| NCT02383511 |
Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet |
https://ClinicalTrials.gov/show/NCT02383511 |
Completed |
Summit Therapeutics |
2015-08-31 |
| NCT02354781 |
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02354781 |
Completed |
Nationwide Children’s Hospital |
2017-11-30 |
| NCT02354352 |
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02354352 |
Completed |
Ohio State University |
2018-05-31 |
| NCT02341053 |
Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy |
https://ClinicalTrials.gov/show/NCT02341053 |
Active, not recruiting |
Gillette Children’s Specialty Healthcare |
2019-12-31 |
| NCT02328482 |
Continuation Protocol to Protocol BBCO-001 |
https://ClinicalTrials.gov/show/NCT02328482 |
Completed |
Bioblast Pharma Ltd. |
2017-10-31 |
| NCT02310906 |
Phase I/II Study of SRP-4053 in DMD Patients |
https://ClinicalTrials.gov/show/NCT02310906 |
Completed |
Sarepta Therapeutics, Inc. |
2019-03-25 |
| NCT02295748 |
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort |
https://ClinicalTrials.gov/show/NCT02295748 |
Completed |
PTC Therapeutics |
2017-08-24 |
| NCT02286947 |
Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02286947 |
Completed |
Sarepta Therapeutics, Inc. |
2017-04-21 |
| NCT02251600 |
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02251600 |
Completed |
PTC Therapeutics |
2015-10-31 |
| NCT02246478 |
A Study of TAS-205 for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02246478 |
Completed |
Taiho Pharmaceutical Co., Ltd. |
2015-06-30 |
| NCT02239224 |
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02239224 |
Completed |
aTyr Pharma, Inc. |
2015-12-21 |
| NCT02235844 |
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02235844 |
Completed |
Allergy and Asthma Consultants, Wichita, Kansas |
2017-09-30 |
| NCT02196467 |
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients |
https://ClinicalTrials.gov/show/NCT02196467 |
Recruiting |
CHU de Quebec-Universite Laval |
2022-01-31 |
| NCT02168114 |
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle |
https://ClinicalTrials.gov/show/NCT02168114 |
Completed |
University of Florida |
2018-01-08 |
| NCT02167217 |
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02167217 |
Completed |
Washington University School of Medicine |
2017-02-22 |
| NCT02159963 |
High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02159963 |
Completed |
Rigshospitalet, Denmark |
2015-09-30 |
| NCT02147639 |
Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02147639 |
Completed |
Cedars-Sinai Medical Center |
2014-05-31 |
| NCT02090959 |
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy |
https://ClinicalTrials.gov/show/NCT02090959 |
Completed |
PTC Therapeutics |
2018-06-21 |
| NCT02081625 |
Exploratory Study of NS-065/NCNP-01 in DMD |
https://ClinicalTrials.gov/show/NCT02081625 |
Completed |
National Center of Neurology and Psychiatry, Japan |
2014-11-30 |
| NCT02056808 |
A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT02056808 |
Completed |
Summit Therapeutics |
2014-05-31 |
| NCT02018731 |
L-citrulline and Metformin in Becker’s Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT02018731 |
Completed |
University Hospital, Basel, Switzerland |
2014-09-30 |
| NCT02255552 |
Study of Eteplirsen in DMD Patients |
https://ClinicalTrials.gov/show/NCT02255552 |
Completed |
Sarepta Therapeutics, Inc. |
2019-06-14 |
| NCT02015481 |
Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients |
https://ClinicalTrials.gov/show/NCT02015481 |
Completed |
Bioblast Pharma Ltd. |
2016-04-30 |
| NCT03354039 |
Tamoxifen in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03354039 |
Recruiting |
University Hospital, Basel, Switzerland |
2020-06-30 |
| NCT01999075 |
Stacking Exercises Aid the Decline in FVC and Sick Time |
https://ClinicalTrials.gov/show/NCT01999075 |
Completed |
Children’s Hospital of Eastern Ontario |
2018-11-22 |
| NCT01995032 |
L-citrulline and Metformin in Duchenne’s Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01995032 |
Completed |
University Hospital, Basel, Switzerland |
2015-10-31 |
| NCT01982695 |
Cardiomyopathy in DMD: Lisinopril vs. Losartan |
https://ClinicalTrials.gov/show/NCT01982695 |
Completed |
Nationwide Children’s Hospital |
2012-08-31 |
| NCT01981915 |
Optimum Insufflation Capacity in NMD |
https://ClinicalTrials.gov/show/NCT01981915 |
Completed |
Universität Duisburg-Essen |
2013-02-28 |
| NCT01976091 |
Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA |
https://ClinicalTrials.gov/show/NCT01976091 |
Completed |
Nationwide Children’s Hospital |
2019-03-14 |
| NCT01954940 |
Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01954940 |
Completed |
Children’s Hospital of Eastern Ontario |
2017-03-31 |
| NCT01921374 |
Mother-caregivers of Children With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01921374 |
Completed |
Federal University of São Paulo |
2013-08-31 |
| NCT01895283 |
The Effect of Aerobic Exercise, on Fitness and Functional Muscle Strength, in Patients With Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01895283 |
Completed |
Rigshospitalet, Denmark |
2014-12-31 |
| NCT01882400 |
Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01882400 |
Completed |
Université de Sherbrooke |
2007-09-30 |
| NCT01874275 |
Duchenne Muscular Dystrophy Clinical Trial |
https://ClinicalTrials.gov/show/NCT01874275 |
Completed |
Alan Neuromedical Technologies, LLC |
2014-09-30 |
| NCT01856868 |
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) |
https://ClinicalTrials.gov/show/NCT01856868 |
Completed |
University of California, Davis |
2018-09-30 |
| NCT01836627 |
A Study to Test Lung Stretch Therapy (Hyperinsufflation) in Children With Collagen VI Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01836627 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2016-04-30 |
| NCT01826487 |
Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01826487 |
Completed |
PTC Therapeutics |
2015-08-31 |
| NCT01826422 |
Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients |
https://ClinicalTrials.gov/show/NCT01826422 |
Completed |
Coordinación de Investigación en Salud, Mexico |
2017-01-31 |
| NCT01823783 |
Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01823783 |
Recruiting |
University Hospital, Montpellier |
2021-01-31 |
| NCT01805024 |
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO) |
https://ClinicalTrials.gov/show/NCT01805024 |
Completed |
Santhera Pharmaceuticals |
2017-12-05 |
| NCT01800604 |
Power Over Pain (POP) Study |
https://ClinicalTrials.gov/show/NCT01800604 |
Completed |
University of Washington |
2018-01-31 |
| NCT01790178 |
Ultrasound in Muscle Biopsy |
https://ClinicalTrials.gov/show/NCT01790178 |
Completed |
Duke University |
2015-10-31 |
| NCT01761292 |
A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD |
https://ClinicalTrials.gov/show/NCT01761292 |
Completed |
Italfarmaco |
2014-12-31 |
| NCT01648634 |
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01648634 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-06-30 |
| NCT01645098 |
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01645098 |
Completed |
Nationwide Children’s Hospital |
2013-04-30 |
| NCT01618331 |
Protein Supplementation and Exercise in Patients With FSH Muscular Dystrophy- a Randomized Placebo Controlled Study |
https://ClinicalTrials.gov/show/NCT01618331 |
Completed |
Rigshospitalet, Denmark |
2013-10-31 |
| NCT01603407 |
Finding the Optimum Regimen for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01603407 |
Completed |
University of Rochester |
2019-11-30 |
| NCT01596803 |
Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD) |
https://ClinicalTrials.gov/show/NCT01596803 |
Completed |
University Hospital, Montpellier |
2012-02-20 |
| NCT01580501 |
PDE Inhibitors in DMD Study (Acute Dosing Study) |
https://ClinicalTrials.gov/show/NCT01580501 |
Completed |
Cedars-Sinai Medical Center |
2013-03-31 |
| NCT01557400 |
Study of Ataluren for Previously Treated Patients With nmDBMD in Europe, Israel, Australia, and Canada |
https://ClinicalTrials.gov/show/NCT01557400 |
Completed |
PTC Therapeutics |
2018-01-31 |
| NCT01540604 |
CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers |
https://ClinicalTrials.gov/show/NCT01540604 |
Completed |
RSPR Pharma AB |
NA |
| NCT01540409 |
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01540409 |
Completed |
Sarepta Therapeutics, Inc. |
2016-04-15 |
| NCT01523964 |
DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls |
https://ClinicalTrials.gov/show/NCT01523964 |
Completed |
Dart Therapeutics. LLC |
2012-08-31 |
| NCT01521546 |
Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01521546 |
Completed |
Ohio State University |
2016-06-30 |
| NCT01519349 |
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis |
https://ClinicalTrials.gov/show/NCT01519349 |
Completed |
Nationwide Children’s Hospital |
2017-10-31 |
| NCT01478022 |
To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 |
https://ClinicalTrials.gov/show/NCT01478022 |
Completed |
Parent Project, Italy |
2016-03-31 |
| NCT01462292 |
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT01462292 |
Completed |
GlaxoSmithKline |
2013-05-21 |
| NCT01438788 |
Low Protein Diet in Patients With Collagen VI Related Myopathies |
https://ClinicalTrials.gov/show/NCT01438788 |
Completed |
Istituto Ortopedico Rizzoli |
2013-06-30 |
| NCT01396239 |
Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients |
https://ClinicalTrials.gov/show/NCT01396239 |
Completed |
Sarepta Therapeutics, Inc. |
2012-02-29 |
| NCT01393444 |
ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis |
https://ClinicalTrials.gov/show/NCT01393444 |
Completed |
University of Pittsburgh |
2015-04-30 |
| NCT01388764 |
Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids |
https://ClinicalTrials.gov/show/NCT01388764 |
Completed |
Massachusetts General Hospital |
2012-05-31 |
| NCT01359670 |
Tadalafil and Sildenafil for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01359670 |
Completed |
Cedars-Sinai Medical Center |
2013-05-31 |
| NCT01350154 |
Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients |
https://ClinicalTrials.gov/show/NCT01350154 |
Completed |
Rigshospitalet, Denmark |
2013-04-30 |
| NCT01344798 |
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C |
https://ClinicalTrials.gov/show/NCT01344798 |
Completed |
Genethon |
2010-06-30 |
| NCT01335295 |
Safety Study of Flavocoxid in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01335295 |
Completed |
University of Messina |
2013-12-31 |
| NCT04392518 |
Telerehabilitation in Proximal Muscle Weakness |
https://ClinicalTrials.gov/show/NCT04392518 |
Recruiting |
Koç University |
2021-09-30 |
| NCT04313595 |
Device for Breathing Frequency Monitoring in Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT04313595 |
Completed |
IRCCS Eugenio Medea |
2019-07-15 |
| NCT04313049 |
LARA: Use of JACO2 Controlled by Joystick or by Voice Control System, in Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT04313049 |
Completed |
IRCCS Eugenio Medea |
2019-11-15 |
| NCT04267354 |
Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) Patients |
https://ClinicalTrials.gov/show/NCT04267354 |
Completed |
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust |
2018-07-14 |
| NCT04264442 |
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) |
https://ClinicalTrials.gov/show/NCT04264442 |
Enrolling by invitation |
Fulcrum Therapeutics |
2024-02-29 |
| NCT04240314 |
AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. |
https://ClinicalTrials.gov/show/NCT04240314 |
Enrolling by invitation |
Nationwide Children’s Hospital |
2023-01-15 |
| NCT04187482 |
Myotonic Dystrophy Type 1 Aerobic Exercise Study |
https://ClinicalTrials.gov/show/NCT04187482 |
Active, not recruiting |
McMaster University |
2020-07-29 |
| NCT04179409 |
A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of Casimersen, Eteplirsen and Golodirsen in Subjects With Duchenne Muscular Dystrophy Carrying Eligible DMD Duplications |
https://ClinicalTrials.gov/show/NCT04179409 |
Enrolling by invitation |
Nationwide Children’s Hospital |
2021-09-15 |
| NCT04173234 |
Aerobic Exercise in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT04173234 |
Recruiting |
Hacettepe University |
2020-01-15 |
| NCT04154098 |
Evaluation of a Textile Scapula Orthosis |
https://ClinicalTrials.gov/show/NCT04154098 |
Recruiting |
Swiss Federal Institute of Technology |
2020-04-30 |
| NCT04129294 |
Exploratory Study of NS-089/NCNP-02 in DMD |
https://ClinicalTrials.gov/show/NCT04129294 |
Enrolling by invitation |
National Center of Neurology and Psychiatry, Japan |
2021-03-31 |
| NCT04060199 |
Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) |
https://ClinicalTrials.gov/show/NCT04060199 |
Recruiting |
NS Pharma, Inc. |
2024-11-30 |
| NCT04054375 |
Weekly Steroids in Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT04054375 |
Active, not recruiting |
Northwestern University |
2020-06-01 |
| NCT04004065 |
Study for Dose Determination of SRP-5051, Then Dose Expansion in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment |
https://ClinicalTrials.gov/show/NCT04004065 |
Recruiting |
Sarepta Therapeutics, Inc. |
2021-08-31 |
| NCT04004000 |
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 |
https://ClinicalTrials.gov/show/NCT04004000 |
Active, not recruiting |
Fulcrum Therapeutics |
2020-12-31 |
| NCT04003974 |
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) |
https://ClinicalTrials.gov/show/NCT04003974 |
Active, not recruiting |
Fulcrum Therapeutics |
2020-11-30 |
| NCT03992430 |
A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Duchenne Muscular Dystrophy (DMD) Patients (MIS51ON) |
https://ClinicalTrials.gov/show/NCT03992430 |
Recruiting |
Sarepta Therapeutics, Inc. |
2024-10-31 |
| NCT03986671 |
Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx |
https://ClinicalTrials.gov/show/NCT03986671 |
Recruiting |
Powell Mansfield Inc. |
2020-10-31 |
| NCT03985878 |
A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03985878 |
Enrolling by invitation |
Sarepta Therapeutics, Inc. |
2026-11-30 |
| NCT03970135 |
Fat and Glucose Metabolism in Fed and Fasted State in Patients With Low Skeletal Muscle Mass |
https://ClinicalTrials.gov/show/NCT03970135 |
Completed |
Rigshospitalet, Denmark |
2017-11-30 |
| NCT03951844 |
Wearability, Saefty and Usability Assessment for the Upper Limb Exoskeleton BRIDGE/EMPATIA |
https://ClinicalTrials.gov/show/NCT03951844 |
Completed |
Politecnico di Milano |
2019-04-02 |
| NCT03936894 |
Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03936894 |
Recruiting |
Children’s National Research Institute |
2020-04-30 |
| NCT03917719 |
An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03917719 |
Enrolling by invitation |
Catabasis Pharmaceuticals |
2022-06-30 |
| NCT03879304 |
Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker. |
https://ClinicalTrials.gov/show/NCT03879304 |
Enrolling by invitation |
University of Malaga |
2020-12-31 |
| NCT03851107 |
The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities |
https://ClinicalTrials.gov/show/NCT03851107 |
Completed |
McGill University |
2018-05-07 |
| NCT03796637 |
A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren |
https://ClinicalTrials.gov/show/NCT03796637 |
Completed |
PTC Therapeutics |
2019-05-24 |
| NCT03789734 |
Safety Study of BLS-M22 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03789734 |
Recruiting |
BioLeaders Corporation |
2020-06-30 |
| NCT03783923 |
A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I) |
https://ClinicalTrials.gov/show/NCT03783923 |
Active, not recruiting |
PTC Therapeutics |
2020-11-30 |
| NCT03779646 |
Bisoprolol in DMD Early Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT03779646 |
Recruiting |
Peking Union Medical College Hospital |
2020-07-01 |
| NCT03777319 |
Spironolactone Versus Prednisolone in DMD |
https://ClinicalTrials.gov/show/NCT03777319 |
Recruiting |
Nationwide Children’s Hospital |
2021-12-31 |
| NCT03769116 |
A Randomized, Double-blind, Placebo-controlled Study of SRP-9001 for Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT03769116 |
Active, not recruiting |
Sarepta Therapeutics, Inc. |
2022-10-10 |
| NCT03760029 |
A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03760029 |
Recruiting |
Pfizer |
2022-09-24 |
| NCT03703882 |
Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03703882 |
Active, not recruiting |
Catabasis Pharmaceuticals |
2020-06-30 |
| NCT03698149 |
ECoG BMI for Motor and Speech Control |
https://ClinicalTrials.gov/show/NCT03698149 |
Recruiting |
University of California, San Francisco |
2024-08-15 |
| NCT03675126 |
An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 |
https://ClinicalTrials.gov/show/NCT03675126 |
Recruiting |
Sarepta Therapeutics, Inc. |
2024-07-31 |
| NCT03652259 |
Gene Delivery Clinical Trial of SRP-9003 for Patients With LGMD2E (Beta-sarcoglycan Deficiency) |
https://ClinicalTrials.gov/show/NCT03652259 |
Active, not recruiting |
Sarepta Therapeutics, Inc. |
2020-12-31 |
| NCT03648827 |
A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) |
https://ClinicalTrials.gov/show/NCT03648827 |
Active, not recruiting |
PTC Therapeutics |
2020-06-30 |
| NCT03627494 |
First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect |
https://ClinicalTrials.gov/show/NCT03627494 |
Completed |
GlaxoSmithKline |
2019-08-26 |
| NCT03611244 |
Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device |
https://ClinicalTrials.gov/show/NCT03611244 |
Recruiting |
Seoul National University Hospital |
2024-12-31 |
| NCT03603288 |
Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) |
https://ClinicalTrials.gov/show/NCT03603288 |
Recruiting |
Santhera Pharmaceuticals |
2023-12-31 |
| NCT02815878 |
Enhance Wellness for Individuals With Long-Term Physical Disabilities |
https://ClinicalTrials.gov/show/NCT02815878 |
Completed |
University of Washington |
2017-11-30 |
| NCT03541070 |
The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03541070 |
Completed |
Hacettepe University |
2017-09-15 |
| NCT03531788 |
Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD |
https://ClinicalTrials.gov/show/NCT03531788 |
Active, not recruiting |
University of Pittsburgh |
2020-12-31 |
| NCT03529240 |
Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption |
https://ClinicalTrials.gov/show/NCT03529240 |
Completed |
Hacettepe University |
2017-08-05 |
| NCT03508947 |
Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03508947 |
Completed |
Wave Life Sciences Ltd. |
2019-03-06 |
| NCT03490214 |
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography |
https://ClinicalTrials.gov/show/NCT03490214 |
Completed |
University of Erlangen-Nürnberg Medical School |
2018-08-01 |
| NCT03439670 |
A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT03439670 |
Recruiting |
ReveraGen BioPharma, Inc. |
2020-05-01 |
| NCT01247207 |
Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) |
https://ClinicalTrials.gov/show/NCT01247207 |
Enrolling by invitation |
PTC Therapeutics |
2020-12-31 |
| NCT01183767 |
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01183767 |
Completed |
Charite University, Berlin, Germany |
2018-09-06 |
| NCT01153932 |
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01153932 |
Completed |
GlaxoSmithKline |
2012-03-31 |
| NCT01128855 |
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects |
https://ClinicalTrials.gov/show/NCT01128855 |
Completed |
GlaxoSmithKline |
2011-10-25 |
| NCT01126697 |
Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies |
https://ClinicalTrials.gov/show/NCT01126697 |
Completed |
Cooperative International Neuromuscular Research Group |
2017-12-31 |
| NCT01116570 |
Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients |
https://ClinicalTrials.gov/show/NCT01116570 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2015-01-31 |
| NCT01070511 |
Tadalafil in Becker Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01070511 |
Completed |
Cedars-Sinai Medical Center |
2012-12-31 |
| NCT01037309 |
Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT01037309 |
Completed |
BioMarin Pharmaceutical |
2013-05-31 |
| NCT01027884 |
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT01027884 |
Completed |
Santhera Pharmaceuticals |
2014-01-31 |
| NCT00912041 |
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia |
https://ClinicalTrials.gov/show/NCT00912041 |
Recruiting |
Massachusetts General Hospital |
2022-09-30 |
| NCT00873782 |
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00873782 |
Completed |
University of North Carolina, Chapel Hill |
2014-02-28 |
| NCT00866112 |
A Randomized Exercise Trial for Wheelchair Users |
https://ClinicalTrials.gov/show/NCT00866112 |
Completed |
University of Kansas Medical Center |
2011-02-28 |
| NCT03811301 |
[BrainConnexion] - Neurodevice Phase II Trial |
https://ClinicalTrials.gov/show/NCT03811301 |
Recruiting |
National Neuroscience Institute |
2021-12-31 |
| NCT00821548 |
Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients |
https://ClinicalTrials.gov/show/NCT00821548 |
Completed |
Centre Hospitalier Universitaire de Nice |
2008-07-31 |
| NCT01254019 |
A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT01254019 |
Completed |
GlaxoSmithKline |
2013-06-28 |
| NCT00844597 |
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients |
https://ClinicalTrials.gov/show/NCT00844597 |
Completed |
Sarepta Therapeutics, Inc. |
2010-06-30 |
| NCT02814019 |
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids |
https://ClinicalTrials.gov/show/NCT02814019 |
Active, not recruiting |
Santhera Pharmaceuticals |
2021-08-31 |
| NCT02579239 |
The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies |
https://ClinicalTrials.gov/show/NCT02579239 |
Completed |
aTyr Pharma, Inc. |
2016-10-05 |
| NCT03532542 |
An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT03532542 |
Enrolling by invitation |
Sarepta Therapeutics, Inc. |
2026-08-10 |
| NCT00773227 |
Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts |
https://ClinicalTrials.gov/show/NCT00773227 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-07-31 |
| NCT00758225 |
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension) |
https://ClinicalTrials.gov/show/NCT00758225 |
Completed |
Santhera Pharmaceuticals |
2011-01-31 |
| NCT00654784 |
Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00654784 |
Completed |
Santhera Pharmaceuticals |
2007-08-31 |
| NCT00592553 |
Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) |
https://ClinicalTrials.gov/show/NCT00592553 |
Completed |
PTC Therapeutics |
2009-12-31 |
| NCT00494195 |
Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) |
https://ClinicalTrials.gov/show/NCT00494195 |
Completed |
Nationwide Children’s Hospital |
2011-06-30 |
| NCT00451074 |
Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons |
https://ClinicalTrials.gov/show/NCT00451074 |
Completed |
Nationwide Children’s Hospital |
2009-07-31 |
| NCT00428935 |
Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00428935 |
Completed |
Nationwide Children’s Hospital |
2009-03-31 |
| NCT00296621 |
Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00296621 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-02-29 |
| NCT00264888 |
Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00264888 |
Completed |
PTC Therapeutics |
2007-05-31 |
| NCT00243789 |
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00243789 |
Completed |
Cooperative International Neuromuscular Research Group |
2007-12-31 |
| NCT00159250 |
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00159250 |
Completed |
Imperial College London |
2008-12-31 |
| NCT00110669 |
High-dose Prednisone in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00110669 |
Completed |
Cooperative International Neuromuscular Research Group |
2007-12-31 |
| NCT00104078 |
Study Evaluating MYO-029 in Adult Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00104078 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00102453 |
Pentoxifylline in Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00102453 |
Completed |
Cooperative International Neuromuscular Research Group |
2006-07-31 |
| NCT00005574 |
Gentamicin Treatment of Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00005574 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00033813 |
KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00033813 |
Completed |
Cooperative International Neuromuscular Research Group |
2006-12-31 |
| NCT00033189 |
An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00033189 |
Completed |
Cooperative International Neuromuscular Research Group |
NA |
| NCT00018109 |
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD) |
https://ClinicalTrials.gov/show/NCT00018109 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00027391 |
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) |
https://ClinicalTrials.gov/show/NCT00027391 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004685 |
Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00004685 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004646 |
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00004646 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00016653 |
Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy |
https://ClinicalTrials.gov/show/NCT00016653 |
Completed |
Cooperative International Neuromuscular Research Group |
NA |